OpenCompanies

Northwest Biotherapeutics Capital Limited

Company number
09103328
Status
Active
Type
Private Limited Company
Incorporated
26 Jun 2014
Nature of business
Buying and selling of own real estate
Other letting and operating of own or leased real estate

Registered office

Co Clyde & Co LLP,,
St Botolph Building, 138 Houndsditch
London
EC3A 7AR

Previous names

  • Aracaris Capital Limited (until 22 Jan 2024)

Officers

NameRoleAppointedResigned
READER, Jason Antony Director 26 Jun 2014 24 Apr 2015
PALMER, Martin William Gordon Director 26 Jun 2014 24 Apr 2015
VISTRA COSEC LIMITED Corporate-Secretary 26 Jun 2014 11 Dec 2023
POWERS, Linda Fairing Director 28 Nov 2014

Control

NameNature of controlNotifiedCeased
Northwest Biotherapeutics Limited Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors
6 Apr 2016

Accounts

Year ended Net assets Cash Employees
31 Dec 2024 -£1,631,119 £41,435 0
31 Dec 2023 -£1,601,840 £29,392 0
31 Dec 2022 - - -
31 Dec 2021 -£1,471,888 £352,183 0
31 Dec 2020 -£1,369,902 £436,169 0
31 Dec 2019 - £30,438 0
31 Dec 2018 - £14,265,217 1
31 Dec 2017 - £31,367 1
31 Dec 2016 -£4,059,536 £118,493 1
31 Dec 2015 -£1,839,313 £383,815 -
30 Jun 2015 -£995,082 £9,452,802 -

Connections

Owned by

Northwest Biotherapeutics Capital Limited → Northwest Biotherapeutics Limited

Companies at the same address

Data